Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Yves Chrétien"'
Autor:
Dominique Debray, Haquima El Mourabit, Fatiha Merabtene, Loïc Brot, Damien Ulveling, Yves Chrétien, Dominique Rainteau, Ivan Moszer, Dominique Wendum, Harry Sokol, Chantal Housset
Publikováno v:
Hepatology Communications, Vol 2, Iss 12, Pp 1533-1549 (2018)
The most typical expression of cystic fibrosis (CF)–related liver disease is a cholangiopathy that can progress to cirrhosis. We aimed to determine the potential impact of environmental and genetic factors on the development of CF‐related cholang
Externí odkaz:
https://doaj.org/article/edbaec0a056648e88baf3447b365b0b5
Autor:
Catherine Dong, Bertrand Condat, Magalie Picon-Coste, Yves Chrétien, Pascal Potier, Béatrice Noblinski, Lionel Arrivé, Marie-Pierre Hauuy, Véronique Barbu, Anware Maftouh, Farid Gaouar, Karima Ben Belkacem, Chantal Housset, Raoul Poupon, David Zanditenas, Olivier Chazouillères, Christophe Corpechot
Publikováno v:
JHEP Reports, Vol 3, Iss 2, Pp 100201- (2021)
Background & Aims: Low-phospholipid-associated cholelithiasis (LPAC) syndrome, a rare genetic form of intrahepatic cholelithiasis in adults, is still poorly understood. We report the results of the largest-ever case-control study of patients with LPA
Externí odkaz:
https://doaj.org/article/f08f48e1c420440a8d56583fcc1a87bc
Autor:
Lynda Aoudjehane, Jérémie Gautheron, Wilfried Le Goff, Claire Goumard, Julia Gilaizeau, Chan Sonavine Nget, Eric Savier, Muhammad Atif, Philippe Lesnik, Romain Morichon, Yves Chrétien, Yvon Calmus, Olivier Scatton, Chantal Housset, Filomena Conti
Publikováno v:
Disease Models & Mechanisms, Vol 13, Iss 4 (2020)
Normothermic perfusion provides a means to rescue steatotic liver grafts, including by pharmacological defatting. In this study, we tested the potential of new drug combinations to trigger defatting in three human culture models, primary hepatocytes
Externí odkaz:
https://doaj.org/article/eff1e63a2c874e1f9e36d2804419bb84
Autor:
Alexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, Joseph Gligorov, Jean-Pierre Lotz, Didier Brault, Eva Comperat, Guillaume Lefèvre, Mathieu Boissan
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227356 (2020)
BACKGROUND:The transmembrane receptor tyrosine kinase HER2 is overexpressed in approximately 15% of breast tumors and correlates with poor clinical prognosis. Several treatments that target HER2 are approved for treatment of HER2-positive metastatic
Externí odkaz:
https://doaj.org/article/bf3795ccb7434f9bb8c0c7cd94d5f75a
Autor:
Christèle Desbois-Mouthon, Olivier Rosmorduc, Chantal Housset, Françoise Praz, Filomena Conti, Olivier Soubrane, Olivier Scatton, Colette Rey, Yves Chrétien, Audrey Clapéron, Dominique Wendum, Lynda Aoudjehane, Laetitia Fartoux, Hamza Chettouh
Supplementary Figure S5 - PDF file 190K, The blockage of EGFR signalling does not alter the subcellular localization of splicing factors in HCC cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::647f3c6c1cd78f018977b30e3f350b93
https://doi.org/10.1158/0008-5472.22393944
https://doi.org/10.1158/0008-5472.22393944
Autor:
Christèle Desbois-Mouthon, Olivier Rosmorduc, Chantal Housset, Françoise Praz, Filomena Conti, Olivier Soubrane, Olivier Scatton, Colette Rey, Yves Chrétien, Audrey Clapéron, Dominique Wendum, Lynda Aoudjehane, Laetitia Fartoux, Hamza Chettouh
Insulin receptor (IR) exists as two isoforms resulting from the alternative splicing of IR pre-mRNA. IR-B promotes the metabolic effects of insulin, whereas IR-A rather signals proliferative effects. IR-B is predominantly expressed in the adult liver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::425b896321bc6d80fd5f53acf281a04e
https://doi.org/10.1158/0008-5472.c.6503913.v1
https://doi.org/10.1158/0008-5472.c.6503913.v1
Autor:
Christèle Desbois-Mouthon, Olivier Rosmorduc, Chantal Housset, Françoise Praz, Filomena Conti, Olivier Soubrane, Olivier Scatton, Colette Rey, Yves Chrétien, Audrey Clapéron, Dominique Wendum, Lynda Aoudjehane, Laetitia Fartoux, Hamza Chettouh
Supplementary Tables S1-S5 - PDF file 94K, Clinicopathologic characteristics of patients with HCC (S1); Pharmacological inhibitors (S2); Antibodies for Western blot and immunofluorescence (S3); Primer pairs for qualitative and quantitative PCR (S4);
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a89fc4ad688f4545a58d9e88f3accd
https://doi.org/10.1158/0008-5472.22393938
https://doi.org/10.1158/0008-5472.22393938
Autor:
Christèle Desbois-Mouthon, Olivier Rosmorduc, Chantal Housset, Françoise Praz, Filomena Conti, Olivier Soubrane, Olivier Scatton, Colette Rey, Yves Chrétien, Audrey Clapéron, Dominique Wendum, Lynda Aoudjehane, Laetitia Fartoux, Hamza Chettouh
Supplementary Figure Legends - PDF file 119K, Legend for Supplementary Figures S1-S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba9915c37efd4baf6e4b87ad8bbc3d2
https://doi.org/10.1158/0008-5472.22393959
https://doi.org/10.1158/0008-5472.22393959
Autor:
Ivan Moszer, Dominique Wendum, Haquima El Mourabit, Dominique Rainteau, Yves Chrétien, Fatiha Merabtene, Harry Sokol, Chantal Housset, Damien Ulveling, Loic Brot, Dominique Debray
Publikováno v:
Hepatology Communications, Vol 2, Iss 12, Pp 1533-1549 (2018)
Hepatology Communications
Hepatology Communications
The most typical expression of cystic fibrosis (CF)-related liver disease is a cholangiopathy that can progress to cirrhosis. We aimed to determine the potential impact of environmental and genetic factors on the development of CF-related cholangiopa
Autor:
Bertrand Condat, Yves Chrétien, Magalie Picon-Coste, Olivier Chazouillères, David Zanditenas, Lionel Arrivé, Chantal Housset, Pascal Potier, Karima Ben Belkacem, Farid Gaouar, Catherine Dong, Marie-Pierre Hauuy, Raoul Poupon, Anware Maftouh, Véronique Barbu, Christophe Corpechot, Béatrice Noblinski
Publikováno v:
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, 2021, 3 (2), pp.100201. ⟨10.1016/j.jhepr.2020.100201⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100201. ⟨10.1016/j.jhepr.2020.100201⟩
JHEP Reports, Vol 3, Iss 2, Pp 100201-(2021)
JHEP Reports
JHEP Reports Innovation in Hepatology, 2021, 3 (2), pp.100201. ⟨10.1016/j.jhepr.2020.100201⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100201. ⟨10.1016/j.jhepr.2020.100201⟩
JHEP Reports, Vol 3, Iss 2, Pp 100201-(2021)
JHEP Reports
Background & Aims Low-phospholipid-associated cholelithiasis (LPAC) syndrome, a rare genetic form of intrahepatic cholelithiasis in adults, is still poorly understood. We report the results of the largest-ever case-control study of patients with LPAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4baa6f3598bde04f01c219301dcb5f0e
https://doi.org/10.1016/j.jhepr.2020.100201
https://doi.org/10.1016/j.jhepr.2020.100201